Sénégal's Viral Hepatitis Prevalence Sparks Calls for Screening

• 85% of Senegalese have markers indicating past contact with the hepatitis B virus.
• 5.7-10% are chronic carriers of the virus, which can lead to cirrhosis and liver cancer.
• Viral hepatitis is a major public health issue in Sénégal, particularly among pregnant women and individuals with a history of blood transfusions or sharing needles.

Les hépatites virales représentent désormais “le premier problème de santé publique” au Sénégal, en raison de leur forte prévalence.

The Sénégal government has identified viral hepatitis as the country's primary public health issue due to its high prevalence. According to Professor Bamba Kane, coordinator of the National Program for Combating Hepatitis (PNLH), 85% of Senegalese have markers indicating past contact with the hepatitis B virus, and 5.7-10% are chronic carriers of the virus. This has significant implications for public health, particularly among pregnant women and individuals with a history of blood transfusions or sharing needles.

The high prevalence of viral hepatitis in Sénégal highlights the need for increased awareness and screening among at-risk populations. Lawyers and compliance officers should be aware that regular screenings for HCV and HBV are essential, particularly for pregnant women and individuals with a history of blood transfusions or sharing needles. This is crucial to prevent long-term liver damage and cancer.

The Sénégal government's recognition of viral hepatitis as a major public health issue underscores the need for increased attention and resources dedicated to combating this disease. The high prevalence of chronic carriers of the virus, particularly among pregnant women and individuals with a history of blood transfusions or sharing needles, highlights the importance of regular screenings and awareness campaigns.

Lawyers and compliance officers in Senegal should be aware of the high prevalence of viral hepatitis, particularly among pregnant women and individuals with a history of blood transfusions or sharing needles, and advise clients to undergo regular screenings for HCV and HBV.

Source: Original reporting via APS